BlackRock »

Blueprint Medicines shares owned by BlackRock

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $716M 6.6M 107.78
2024-03-31 $612M 6.4M 94.86
2023-09-30 $331M 6.6M 50.22
2023-06-30 $413M 6.5M 63.20
2023-03-31 $298M 6.6M 44.99
2022-12-31 $275M 6.3M 43.81
2022-06-30 $267M 5.3M 50.51
2021-06-30 $456M 5.2M 87.97
2021-03-31 $490M 5.0M 97.23
2020-12-31 $567M 5.1M 112.15
2020-09-30 $444M 4.8M 92.70
2020-03-31 $274M 4.7M 58.48
2019-12-31 $341M 4.3M 80.10
2019-09-30 $316M 4.3M 73.47
2019-06-30 $388M 4.1M 94.33
2019-03-31 $272M 3.4M 80.05
2018-12-31 $186M 3.4M 53.90
2018-09-30 $269M 3.4M 78.07
2018-06-30 $211M 3.3M 63.47
2018-03-31 $299M 3.3M 91.66
2017-09-30 $208M 3.0M 69.79
2016-12-31 $55k 2.0k 27.98
2016-09-30 $59k 2.0k 29.95
2016-06-30 $26k 1.3k 20.05
2016-03-31 $11k 587 18.87
2015-12-31 $6.0k 216 27.78
2015-09-30 $5.0k 216 23.15
2015-06-30 $6.0k 216 27.78